NAMS
NewAmsterdam Pharma Company NV

417
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 05,
Pre-Market

Estimated EPS

-$0.40

Estimated Rev

$5.29M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.40
--
--
N/A
Q2 '25
-$0.20
--
--
N/A
Q1 '25
-$0.35
--
--
N/A
Q4 '24
-$0.76
--
--
N/A
Q3 '24
-$0.50
-$0.18
63.94%
BEAT

Latest NAMS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.